Indications and uses
INDICATIONS: For cauterization of skin or mucous membrane and for removing warts and granulated tissue.
INDICATIONS: For cauterization of skin or mucous membrane and for removing warts and granulated tissue.
Moisten the applicator tip with distilled, deionized or purified water and apply the silver nitrate to the affected area by holding, rubbing, or rotating the tip along the affected tissue. The strength of the action is controlled by the dilution with distilled, deionized or purified water. One silver nitrate applicator is generally sufficient for each application. The action of the silver nitrate can be stopped by...
Store in the closed package at room temperature in a dry place protected from light. Silver nitrate will oxidize and turn dark brown upon exposure to light, however this does not affect the product’s potency or utility. Exposure to moisture can cause the tip to break or loosen from the applicator. Store away from vaporous chemicals.
INDICATIONS: For cauterization of skin or mucous membrane and for removing warts and granulated tissue.
Moisten the applicator tip with distilled, deionized or purified water and apply the silver nitrate to the affected area by holding, rubbing, or rotating the tip along the affected tissue. The strength of the action is controlled by the dilution with distilled, deionized or purified water. One silver nitrate applicator is generally sufficient for each application. The action of the silver nitrate can be stopped by washing the area with saline solution (0.9% sodium chloride). Using saline solution to wet the applicator tips, or residual saline from wound flushing/washing will interfere with the action of silver nitrate resulting in cauterization failure. Only use distilled, deionized or purified water to wet applicator tips. Blot dry wounds that have been flushed/washed with saline prior to applying silver nitrate.
Stick: 70 mg
Silver salts stain tissue black due to deposition of reduced silver. The stain gradually disappears within a period of two weeks. Prolonged ingestion or absorption of silver compounds leads to deposition of silver in connective tissues, producing a slate-blue discoloration of the skin known as argyria. This discoloration may also appear on mucous membranes such as the margins of gums. The sclera of the eye is also stained.
WARNING: KEEP OUT OF REACH OF CHILDREN. The active ingredients are poisonous and may be fatal when ingested in sufficient doses. The symptoms include toxic gastroenteritis, which may lead to coma, convulsion, paralysis and profound alteration of respiration. If poisoning occurs, immediately consult a physician.
WARNING: DO NOT USE ON THE EYES. In case of eye contact, hold eyes open and immediately flush thoroughly with water for at least 15 minutes and consult a physician.
CAUTION: SILVER NITRATE IS A CAUSTIC SUBSTANCE. Chemical burns may result from inappropriate use of product.
• Wear chemical resistant gloves while using this product. Wear other appropriate personal protective equipment as needed.
• Take care to confine the silver nitrate to the area being treated by using an appropriate physical or chemical barrier to prevent staining or burning of untreated tissue.
• Skin contact time with applicators should be minimal when used on thin delicate skin or neonates.
• Avoid prolonged contact with skin or other surfaces since staining may occur.
CAUTION: FEDERAL LAW PROHIBITS DISPENSING WITHOUT PRESCRIPTION.
Store in the closed package at room temperature in a dry place protected from light. Silver nitrate will oxidize and turn dark brown upon exposure to light, however this does not affect the product’s potency or utility. Exposure to moisture can cause the tip to break or loosen from the applicator. Store away from vaporous chemicals.
Expired or unused applicators may be returned for disposal to: GF Health Products, Inc., 33 Plan Way, Bldg. # 2, Warwick, RI 02886, or disposed of according to applicable federal, state and local regulations.
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1117536 | potassium nitrate 25 % / silver nitrate 75 % Medicated Pad | PSN | 3 |
| 1117536 | potassium nitrate 250 MG/ML / silver nitrate 750 MG/ML Medicated Pad | SCD | 3 |
| 1117536 | K+ nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated Pad | SY | 3 |
| 1117536 | Pot nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated Pad | SY | 3 |
| 1117536 | potassium nitrate 25 % / silver nitrate 75 % Topical Sponge | SY | 3 |
| 1117536 | potassium nitrate 25 % / silver nitrate 75 % Topical Stick | SY | 3 |
| 1117536 | potassium nitrate 25 % / silver nitrate 75 % Topical Swab | SY | 3 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6cca4355-1206-91f7-02de-17eef38a8622 | Product name | 1 | 20140508 |
| 751c581a-bf64-2fd7-b3ec-ca02c83e4a00 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 12165-200-03 | GRAFCOAPPLICATOR 30 CM | 100 in 1 TUBE | STICK | 100 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 12165-200-03 | EA - Each | 12165-200 | a58721d9-a18d-46a7-982d-74ade3b28e2d | 1 | 2021-05-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 12165-200 | 12165-200-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILVER NITRATE | 95IT3W8JZE | ACTIB |
| POTASSIUM NITRATE | RU45X2JN0Z | ACTIB |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GRAFCO APPLICATOR 30 CM | SILVER NITRATE | GF Health Products, Inc. | 8c4f8326-af2e-4658-a247-e29cd1c0fd68 | 2019-12-04 | Warnings | 12165-200-03 12165-200 12165020003 91d77ae9-6d0f-4f0e-a7b2-b6a270ce90a4 8c4f8326-af2e-4658-a247-e29cd1c0fd68 |
Adverse event summaries are temporarily unavailable. Other product information remains available.